Just Pick the Day. And We’ll Help You Save It.
BOOTH #1137 | New Orleans, LA
Let’s meet @ASGCT and explore together if strengths like these from Viralgen can help you conquer your project:
Forecast your serotype’s performance from our 1,500+ AAV runs
Leverage Pro10™, our AAV platofrm designed for best-in-class speed to scale
Partner with our team of experts that has 100% success rate in IND/IMPD dossier submissions
Schedule A Meeting
Streamlining Advanced Therapy Medicinal Product Manufacturing: A Platform Approach for Accelerating Gene Therapy Commercialization at Viralgen
Join us live with Cesar Trigueros:
May 15, 5:30-7pm CT, Poster Hall I2
May 15, 1:30pm, Viralgen Booth #1137
Poster # AMA988
Benefits of High-Throughput Sequencing-Based Methods for In-Depth Characterization of Recombinant AAV Products
Join us live with Sonia Stinus:
May 14, 5:30-7pm CT,
Poster Hall I2
May 14, 1:30pm, Viralgen Booth #1137
Poster # AMA905
Enhancing the Upstream Performance of Adeno-Associated Virus (AAV) Vector Manufacturing via Multivariate Data Analysis
Join us live with Ainara Apezteguia:
May 15, 5:30-7pm CT,
Poster Hall I2
May 15, 10:00am, Viralgen Booth #1137
Poster # AMA1624
Integrating Raman Spectroscopy and Genome-Scale Modeling to Enhance AAV Upstream Manufacturing
Join us live with Itsasne Arangoa:
May 13, 6-7:30pm CT,
Poster Hall I2
May 14, 10:00am, Viralgen Booth #1137
Poster # AMA1539
SPONSORED SYMPOSIUM
Cytiva: Could cell line technologies bring disruptive changes to gene therapy manufacturing?
Wednesday, May 14
12:15pm - 1:15pm
Room 271-273
Jacob Smith
Head of Tech Development & CMC at Viralgen
Tools & Technology Forum

Presented by María Iglesias
Head of IT & Digital, Viralgen
A Rock in a Storm: Using Data as Your Foundation to Speed and De-risk AAV Manufacturing
Friday, May 16, 1:30pm, Exhibit Hall Theater
Let’s Connect
Bayer fully supports coordinated vulnerability disclosure and encourages security researchers who choose to engage in these actions to do so in a responsible manner.
Coordinated Vulnerability Disclosure Statement